Dr. Chaves has 20 years of experience working in public health, especially on pharmaceutical policies and barriers to access to medicines in Brazil.
From 2013 to 2019, she worked as a researcher at the Department of Medicines Policy and Pharmaceutical Services (NAF) at the Sergio Arouca National School of Public Health/Oswaldo Cruz Foundation (ENSP/Fiocruz, Brazil), where she is currently on a licence. She led research projects focusing on the analysis of approaches to stimulate local production of medicines and their connections with health policies to increase access.
From July 2023 to July 2024, she was a visiting fellow at the Institute of Applied Economic Research (IPEA) in Brazil.
In 2023, she was a lecturer at the L'école des ingénieur·e·s en biotechnologies (SupBiotech) in Paris, France and, in 2022, a visiting faculty for the course “An introduction to governing pandemics” for the Interdisciplinary Master on International and Development Studies (MINT) at the Geneva Graduate Institute.
Prior to that, she has worked on access with civil society organisations in Brazil, such as the MSF Access Campaign and the Brazilian Interdisciplinary Aids Association (ABIA). She has been involved in different projects on analysis and access to health technologies for civil society, non-for-profit and international organisations.
Her current study aims to explore in what ways recent movements at the international level for regionalisation and stronger manufacturing capacity are influencing approaches to intellectual property rights (IPR), industrial and health policies in Brazil, considering recent movements during and after the COVID-19 pandemic.
SELECTED PUBLICATIONS:
- Chaves, G. C., Miranda, P., Pereira, L. D. S., & Zucoloto, G. F. (2024). Panorama mundial dos acordos no setor farmacêutico no período de 1992 a 2021.In: Tecnologias e preços no mercado de medicamentos. Rio de Janeiro: IPEA, 427-475. Available at https://repositorio.ipea.gov.br/bitstream/11058/16363/1/Cap_10_Panorama_mundial_acordos_setor_farmaceutico_periodo_1992_a_2021.pdf
(Chapter in Portugues, title in English: World overview of agreements in the pharmaceutical sector from 1992-2021) - Bacigalupo, M. L., Pignataro, M. F., Scopel, C. T., Kondratyuk, S., Mellouk, O., & Chaves, G. C. (2023). Unveiling patenting strategies of therapeutics and vaccines: evergreening in the context of COVID-19 pandemic. Frontiers in Medicine, 10, 1287542. Available at
https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2023.1287542/full - Barbeitas, M. M., Antonielli, A. B., Chaves, G. C., & Kameda, K. (2023). Towards equity in health: for an agenda for research and development and local production driven by the multiple needs of the Brazilian Unified National Health System. Cadernos de Saúde Pública, 39, e00073623. Available at https://www.scielo.br/j/csp/a/3VsSrLvVp7BY44jWjQP5Ftf/?format=pdf&lang=en
- Chaves GC, Oliveira MA, Bermudez JAZ (2021) Brazil: Patent Barriers and Access to Medicines Through the Public Health System, in Intellectual Property Law and Access to Medicines - TRIPS Agreement, Health, and Pharmaceuticals (ed. Ragavan S and Vanni A).